The long-term outcome of patients who relapse after chemotherapy for non-seminomatous germ cell tumours.

Ledermann, J A; Holden, L; Newlands, E S; Begent, R H; Rustin, G J; Bagshawe, K D; Brampton, M

Ledermann, J A; Holden, L; Newlands, E S; Begent, R H; Rustin, G J; Bagshawe, K D; Brampton, M.

Affiliation

Ledermann JA; Department of Medical Oncology, Charing Cross Hospital, London, UK.

Br J Urol ; 74(2): 225-30, 1994 Aug.

Article in En | MEDLINE | ID: mdl-7522874

Subject(s)

Antineoplastic Combined Chemotherapy Protocols/therapeutic use; Genital Neoplasms, Male/drug therapy; Germinoma/drug therapy; Neoplasm Recurrence, Local/drug therapy; Adolescent; Adult; Bleomycin/administration & dosage; Cisplatin/administration & dosage; Cyclophosphamide/administration & dosage; Cytarabine/administration & dosage; Dactinomycin/administration & dosage; Etoposide/administration & dosage; Genital Neoplasms, Male/mortality; Germinoma/mortality; Humans; Male; Methotrexate/administration & dosage; Neoplasm Recurrence, Local/mortality; Prognosis; Retrospective Studies; Risk Factors; Survival Analysis; Time Factors; Vinblastine/administration & dosage; Vincristine/administration & dosage

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Antineoplastic Combined Chemotherapy Protocols / Germinoma / Genital Neoplasms, Male / Neoplasm Recurrence, Local Type of study: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adolescent / Adult / Humans / Male Language: En Journal: Br J Urol Year: 1994 Document type: Article Affiliation country: United kingdom Country of publication: United kingdom

Search on Google

Add to My VHL

XML

PubMed Links